Navigation Links
Cambrex Reports First Quarter of 2011 Results
Date:5/5/2011

antly higher year over year.  In addition to the increases in sales volumes for some of our larger custom manufacturing products, we continue to see strong orders for our generic APIs.  Cambrex Zenara is off to a positive start and has been asked to increase production as part of their customer's launch of a leading nicotine replacement therapy product in India."

Guidance – Continuing OperationsThe Company continues to expect that sales for 2011, excluding the impact of foreign currency, will increase between 3% and 7% versus 2010, and that full year 2011 EBITDA will be between $43 and $49 million.  EBITDA guidance is for continuing operations and excludes the impact of any M&A or restructuring activities.  The above guidance does not reflect Cambrex Zenara, which is accounted for using the equity method, and as such is not consolidated into the Company's results.  Cambrex's income statement reflects 51% of Cambrex Zenara's net results as Equity in Losses of Partially-Owned Affiliate.  For 2011, Cambrex Zenara is expected to have revenues in the low to mid single digit millions and a small EBITDA loss.

Capital expenditures are expected to be approximately $14 to $17 million and depreciation is expected to be $21 to $23 million in 2011.

The financial information contained in this press release is unaudited, subject to revision and should not be considered final until the Company's first quarter 2011 Form 10-Q is filed with the SEC.

Conference Call and WebcastThe Conference Call to discuss first quarter of 2011 results will begin at 8:30 a.m. Eastern Time on Friday, May 6, 2011 and last approximately 45 minutes.  Those wishing to participate should call 1-888-299-7230 for domestic and +1-719-325-2168 for international.  Please use the pass code 7839366 and call approximately 10 minutes prior to start time.  A webcast is available from the Investors section on the Cam
'/>"/>

SOURCE Cambrex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cambrex Reports Fourth Quarter and Full Year 2010 Results
2. Cambrex to Announce Fourth Quarter 2010 Financial Results on February 10, 2011
3. Cambrex Zenara Manufacturing Facility Receives European GMP Approval
4. Shawn P. Cavanagh Appointed Chief Operating Officer of Cambrex
5. Cambrex Zenara Supplies Product for Launch of NicoretteĀ® in India
6. Cambrex Acquires Stake in Zenara Pharma
7. Cambrex to Announce Third Quarter 2010 Financial Results on November 3, 2010
8. Cambrex Acquires IEP GmbH
9. Cambrex Reports Third Quarter 2009 Results
10. Cambrex to Announce Third Quarter 2009 Financial Results on November 3, 2009
11. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Wins 2009 Silver Innovation Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Most osteoporosis patients want a choice in the ... sponsored by Mission Pharmacal Company. The survey, conducted by ... support community, revealed that 74 percent of osteoporosis patients ... form other than a pill or a tablet. ...
(Date:1/15/2014)... Corporation (the "Company") (NASDAQ: CLSN ) today ... to purchase an aggregate of approximately $15 million of ... offering, led by a dedicated health care fund. ... these investors pursuant to which the Company agreed to ...
(Date:1/15/2014)... LOUISVILLE, Ky. , Jan. 15, 2014  Manufacturers, ... technologies must be able to protect their most ... (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because ... Industry, it steadfastly remains one of the most ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2
... Pa., June 30, 2011 Endo Pharmaceuticals (Nasdaq: ... study comparing the novel investigational drug axomadol against placebo in ... back pain. The results indicate that axomadol did not meet ... analyses of the data and evaluating the path forward for ...
... 30, 2011 UCB and Harvard University officially launched ... took place in Boston last night in the presence ... (Photo: http://photos.prnewswire.com/prnh/20110630/NY28450 ) The ... and academia, with Harvard scientists continuing their research that ...
Cached Medicine Technology:Endo Announces Topline Results From Phase 2 Study of Axomadol in Chronic Low Back Pain 2UCB Launches Research Alliance with Harvard University 2UCB Launches Research Alliance with Harvard University 3
(Date:7/10/2014)... health concerns in the United States, with 32 percent ... 2012. As health problems such as childhood obesity grow, ... the problem. , A new study, led by Jenine ... at Washington University in St. Louis, examined the use ... conversations about the issue of overweight kids. , The ...
(Date:7/10/2014)... Human Services (HHS) has announced a three-year grant to ... totaling $4.7 million to support a new national model ... , Titled "Evidence-Conformant Oncology Care," the project will ... care for adult cancer patients with late-stage disease, significant ... , "We believe that the best cancer ...
(Date:7/10/2014)... Up to 70% of Parkinson,s disease (PD) ... quality of life. Some patients have disturbed sleep/wake ... asleep, while other patients may be subject to ... extreme, PD patients may exhibit REM-sleep behavior disorder ... re-enactment, even before motor symptoms appear. A review ...
(Date:7/10/2014)... at the University of Huddersfield could help to improve ... food products such as butter, mayonnaise, yoghurt and ... an international profile for her work. , Katerina gained ... the University and now she has embarked on research ... Vassilis Kontogiorgos, she is investigating the potential of carbohydrates ...
(Date:7/10/2014)... identifying the clinical indicators most strongly associated with concussion ... developing evidence-based guidelines for concussion diagnosis, prognosis, and treatment, ... Neurosurgery , official journal of the ... by Lippincott Williams & Wilkins , a part ... Based on analysis of the best available research data, ...
Breaking Medicine News(10 mins):Health News:Study looks at how Twitter can be used to address specific health issues 2Health News:UH Case Medical Center awarded $4.7 million grant from HHS 2Health News:UH Case Medical Center awarded $4.7 million grant from HHS 3Health News:Sleep disturbances, common in Parkinson's disease, can be early indicator of disease onset 2Health News:World interest in research work on the benefits of the Okra plant 2Health News:What's a concussion? Review identifies four evidence-based indicators 2Health News:What's a concussion? Review identifies four evidence-based indicators 3
... typically ones headed by a medical doctor rather than a manager. ... makes a good hospital. The research, to be published in ... first of its kind. Its conclusions run counter to a ... -- not those with a medical degree -- at the helm ...
... By pairing an award-winning remote-detection version of NMR/MRI ... designed for microfluidic chips, researchers with the U.S. ... (Berkeley Lab) have opened the door to a ... that would be impractical if not impossible with ...
... , WEDNESDAY, July 6 (HealthDay News) -- Brief, voluntary ... reduce their use of the drug, according to a new ... to these discussions about marijuana was more effective than merely ... drug. Marijuana is a common drug choice for teens ...
... form of brain tumor in people. Research published in ... Design offers a novel way to determine what ... to form. Understanding the problems at the molecular level ... in glioblastoma and ultimately lead to treatments or even ...
... , WEDNESDAY, July 6 (HealthDay News) -- Being satisfied with ... the finding of a new study that included almost 8,000 ... their satisfaction in seven areas of their lives: romantic relationships, ... self. Over a follow-up period of about six years, ...
... ablative radiotherapy and improvements in surgical care in early-stage ... elderly Dutch patients, according to a population-based study presented ... Amsterdam, hosted by the International Association for the Study ... Dutch non-small cell lung cancer (NSCLC) patients increased by ...
Cached Medicine News:Health News:The best hospitals are run by physicians 2Health News:Berkeley Lab researchers apply NMR/MRI to microfluidic chromatography 2Health News:Berkeley Lab researchers apply NMR/MRI to microfluidic chromatography 3Health News:Berkeley Lab researchers apply NMR/MRI to microfluidic chromatography 4Health News:Talking to Teens May Help Them Cut Back on Pot Smoking 2Health News:What causes brain cancer? 2Health News:Elderly Dutch lung patients' survival improved by new treatment options between 2003-2009 2
... interoperative placement to stent the ... and continent urinary diversions. Supplied ... for one-time use. CAUTION: Periodic ... not remain indwelling more than ...
... a device that provides effective cutting and simultaneous ... to provide the urologist with the same touch ... the approximate speed and the same ease of ... but with a 45% greater zone of ...
Used for stone manipulation and removal in the renal pelvis under direct vision. Supplied sterile in peel-open packages. Intended for one-time use....
Used for stone manipulation and removal in the renal pelvis under direct vision. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: